文献速递类风湿关节炎

改善类风湿因子和抗瓜氨酸化蛋白/肽抗体检测结果临床解读的多中心研究

Multicentre study to improve clinical interpretation of rheumatoid factor and anti-citrullinated protein/peptide antibodies test results.
PubMed 文献 · RMD Open · 2022-01-01

该多中心研究评估了13家公司共6种RF非同种型特异性、3种RF IgM同种型特异性和9种ACPA IgG检测方法,使用398例RA患者和1073例疾病对照的诊断样本。研究发现按厂商切点各检测方法的诊断灵敏度和特异度差异很大;基于预设特异度确定抗体水平阈值并定义检测结果区间后,各RF和ACPA检测方法的区间特异性似然比一致,且ACPA的似然比高于RF。

要点

  • 按厂商切点,各RF和ACPA检测方法的诊断灵敏度和特异度差异很大。
  • 基于预设特异度确定阈值并划分检测结果区间后,各检测方法的区间特异性似然比一致。
  • 所有检测方法中,RA的似然比随抗体水平升高而增加,ACPA的似然比高于RF。

核心结论

  • 确定抗体水平阈值并赋予检测结果区间特异性似然比,可使所有RF和ACPA检测方法的临床解读趋于一致。

研究设计与样本

  • 多中心研究,评估13家公司共6种RF非同种型特异性检测、3种RF IgM同种型特异性检测和9种ACPA免疫球蛋白G检测,使用398例RA患者和1073例疾病对照的诊断样本。

主要发现

  • 按厂商提出的切点,各检测方法间的诊断灵敏度和特异度存在很大变异。
  • 基于预设特异度确定抗体水平阈值,并用于定义检测结果区间。
  • 各RF和ACPA检测方法的检测结果区间特异性似然比一致。
  • 所有检测方法中,RA的似然比随抗体水平升高而增加。
  • ACPA的似然比高于RF;在相当比例(>22%)的RA患者中,ACPA水平对应的似然比>80。

关键数值与推荐

  • 基于预设特异度确定抗体水平阈值,并定义检测结果区间。
  • 各检测方法的检测结果区间特异性似然比一致;所有检测方法中RA似然比随抗体水平升高而增加,ACPA似然比高于RF。
  • 在>22%的RA患者中,ACPA水平对应的似然比>80。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Rheumatoid factor (RF) and anti-citrullinated protein/peptide antibodies (ACPA) are important biomarkers for diagnosis of rheumatoid arthritis (RA). However, there is poor harmonisation of RF and ACPA assays. The aim of this study was to refine RF and ACPA interpretation across commercial assays. MATERIALS AND METHODS: Six total RF isotype-non-specific assays, 3 RF IgM isotype-specific assays and 9 ACPA immunoglobulin G assays of 13 different companies were evaluated using 398 diagnostic samples from patients with RA and 1073 disease controls. RESULTS: Using cut-offs proposed by the manufacturer, there was a large variability in diagnostic sensitivity and specificity between assays. Thresholds of antibody levels were determined based on predefined specificities and used to define test result intervals. Test result interval-specific likelihood ratios (LRs) were concordant across the different RF and ACPA assays. For all assays, the LR for RA increased with increasing antibody level. Higher LRs were found for ACPA than for RF. ACPA levels associated with LRs >80 were found in a substantial fraction (>22%) of patients with RA. CONCLUSION: Defining thresholds for antibody levels and assigning test result interval-specific LRs allows alignment of clinical interpretation for all RF and ACPA assays.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Van Hoovels L, Vander Cruyssen B, Sieghart D, et al. Multicentre study to improve clinical interpretation of rheumatoid factor and anti-citrullinated protein/peptide antibodies test results. RMD Open. 2022. PMID: 35321875. doi:10.1136/rmdopen-2021-002099

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。